{{Rsnum
|rsid=3754446
|Gene=GSTM5
|Chromosome=1
|position=109710619
|Orientation=minus
|GMAF=0.3728
|Gene_s=GSTM5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 9.9 | 45.0 | 45.0
| HCB | 44.0 | 46.3 | 9.7
| JPT | 43.6 | 44.5 | 11.8
| YRI | 0.0 | 1.4 | 98.6
| ASW | 1.8 | 8.8 | 89.5
| CHB | 44.0 | 46.3 | 9.7
| CHD | 44.3 | 47.2 | 8.5
| GIH | 12.9 | 50.5 | 36.6
| LWK | 0.0 | 0.0 | 0.0
| MEX | 28.1 | 54.4 | 17.5
| MKK | 0.0 | 9.7 | 90.3
| TSI | 8.8 | 45.1 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=23677058
|Title=Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}